In general, GRPR antagonists are cleared more rapidly from the pancreas than from the tumor over time, which is why tumor-to-pancreas ratios at 4 or 24 h p.i. are noticeably higher than at 1 h p.i. [17,24,25]. Here, GRPR is linked to neoplasm.